Company news

Dexcom, Inc. (NASDAQ:DXCM) news

Dexcom, Inc. news releases on 6ix. Latest, Oct 6, 2026: Dexcom U Enters Season 5 With a Record Roster and Evidence That Diabetes Stigma Among Young Athletes…

Dexcom, Inc. (NASDAQ:DXCM) news

Press releases & updates

Dexcom U Enters Season 5 With a Record Roster and Evidence That Diabetes Stigma Among Young Athletes Is Fading

Dexcom Publishes New Report During EASD 2026 on Type 2 Diabetes Revealing Critical Opportunity for Global Diabetes Care

Dexcom Promotes Jereme Sylvain to Chief Operating Officer

Dexcom Appoints Glenn Boehnlein to Board of Directors

Dexcom Reports Second Quarter 2026 Financial Results

Dexcom Announced as First Participant Selected for FDA's TEMPO Digital Health Devices Pilot Program

Dexcom G7 15 Day Receives Health Canada Authorization: Extending Wear and Continuity for Canadian Adults Living with Diabetes

Dexcom Schedules Second Quarter 2026 Earnings Release and Conference Call for July 30, 2026 at 4:30 p.m. Eastern Time

Dexcom Further Advances Vision of Glucose Biosensing for All

Disc Medicine Presents Positive Clinical Updates at the 2026 European Hematology Association (EHA) Annual Meeting

Dexcom CONNECT Study: The Most Significant Clinical Study Demonstrating CGM Benefits for People with Type 2 Diabetes Not Using Insulin

Dexcom Reaffirms CGM Benefits for All People With Diabetes and Continues Momentum Toward Earlier Stage Intervention and Preventative Care at ADA 2026

Dexcom Releases Customer Advisory Council Report, Outlining Ongoing Commitments to Enhancing Product Performance and User Experience

Dexcom Uncovers Theft of Scrapped Product, Notifies Potentially Impacted Users

Redefining CGM for People With Type 2 Diabetes: Dexcom Announces Dexcom Flex in Germany

Dexcom Announces Governance Enhancements Ahead of 2026 Investor Day

Dexcom to Host Investor Day on May 14, 2026

Dexcom Reports First Quarter 2026 Financial Results

Middle East and Africa Continuous Glucose Monitoring Market Forecast and Company Analysis Report 2026-2034 Featuring Dexcom, Medtronic, Senseonics, Abbott Diabetes Care, and GlySens

Dexcom Schedules First Quarter 2026 Earnings Release and Conference Call for April 30, 2026 at 4:30 p.m. Eastern Time

Dexcom Showcases Breakthrough Outcomes for People With Type 2 Diabetes and Product Roadmap at ATTD 2026

Dexcom Appoints Rick Osterloh to Board of Directors

Dexcom Reports Fourth Quarter and Fiscal Year 2025 Financial Results

Insulet Launches Omnipod® 5 and Omnipod Discover™ in the Middle East to Transform Diabetes Care

Stelo Adds Enhanced Smart Meal Logging Features as Dexcom Continues to Transform Personal Glucose Management

Dexcom Schedules Fourth Quarter and Fiscal Year 2025 Earnings Release and Conference Call for February 12, 2026 at 4:30 p.m. Eastern Time.

Dexcom Reports Preliminary, Unaudited Results for the Fourth Quarter and Fiscal Year 2025 and Initial 2026 Outlook

Dexcom Enters Next Era of Continued Innovation With Jake Leach as President and Chief Executive Officer

Listening to Healthcare Professionals: Dexcom Launches New Education Offering, Dexcom Academy

GlucoGuard a Division of American Diversified Holdings (ADHC) Successfully Submits Level 2 App Integration Through Dexcom's Developer Partner Program

Dexcom G7 15 Day Continuous Glucose Monitoring System to Launch on Dec. 1 in the United States

Dexcom Smart Basal Receives FDA Clearance Becoming the First and Only CGM-integrated Basal Insulin Dosing Optimizer for Type 2 Diabetes

Dexcom Reveals Global Diabetes Advocates: New Voices for Diabetes Awareness This World Diabetes Day

Carrot Partners with ŌURA and Dexcom to Deliver Deeper Insights and Experiences for Members on Fertility, Family-Building, and Hormonal Health Journeys

Québec Expands Access to Dexcom CGM under the Régie de l'assurance maladie du Québec (RAMQ)

Dexcom Reports Third Quarter 2025 Financial Results and Updates Full Year 2025 Guidance

Dexcom Appoints Euan Ashley to Board of Directors

Dexcom Schedules Third Quarter 2025 Earnings Release and Conference Call for October 30, 2025 at 4:30 p.m. Eastern Time.

Dexcom Spotlights Upcoming Feature Launches, Improved Health Outcomes and Cost-Effectiveness With Dexcom Glucose Biosensing at EASD 2025

Dexcom Launches Its First Open Call to Uncover the Next Diabetes Advocates Ahead of World Diabetes Day

Dexcom Announces Upcoming Conference Presentations

FriskaAi and Dexcom Enter CGM Data Integration Agreement

ViCentra to Bring Smartphone-Based Closed Loop Therapy to People with Diabetes in Early 2026

Garmin announces collaborations with leading brands for Garmin Marathon Series

Ontario Expands Access to Dexcom G7 CGM Under the Ontario Drug Benefit (ODB) Program

Dexcom Reports Second Quarter 2025 Financial Results, Updates Full Year 2025 Guidance and Announces CEO Succession Plan

Dexcom Launches Revolutionary AI-Powered Meal Logging Feature Across Glucose Biosensing Portfolio

Tenovi Expands Access to Glucose Data for Remote Patient Monitoring and Cardiometabolic Programs Through Dexcom Integration

Dexcom Unveils Season 4 Roster for Game-Changing NIL Program at Signing Day Camp Hosted by Mark Andrews

Dexcom Schedules Second Quarter 2025 Earnings Release and Conference Call for July 30, 2025 at 4:30 p.m. Eastern Time.